Medpace CFO Kevin Brady Reports Option Exercise and Stock Sale

Rhea-AI Filing Summary

Medpace Holdings, Inc. (MEDP)11/21/2025, he exercised an employee stock option for 3,000 shares of common stock at an exercise price of $166.73 per share, increasing his holdings, then sold 3,000 shares of common stock in a market transaction coded as a sale. The reported sale price is a weighted average of $590.35 per share, based on multiple trades between $590.00 and $590.72 placed via a limit order during an open trading window.

On the same date, Brady also gifted 170 shares of common stock to a donor-advised fund. After these transactions, he directly beneficially owned 5,830 shares of Medpace common stock. The employee stock option for 3,000 shares, which had vested in full on October 27, 2025, was fully exercised and no longer outstanding following the reported activity.

11/25/2025 - 04:40 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Brady Kevin M.

(Last) (First) (Middle)

C/O MEDPACE HOLDINGS, INC.

5375 MEDPACE WAY

(Street)

CINCINNATI OH 45227

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Medpace Holdings, Inc. [ MEDP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CFO & Treasurer

3. Date of Earliest Transaction (Month/Day/Year)
11/21/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/21/2025		M		3,000	A	$166.73	9,000	D
Common Stock	11/21/2025		S(1)		3,000	D	$590.35(2)	6,000	D
Common Stock	11/21/2025		G(3)		170	D	$0	5,830	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	$166.73	11/21/2025		M			3,000	(4)	10/27/2026	Common Stock	3,000	$0	0	D

Explanation of Responses:

1. The transactions reported on this line were effected pursuant to a limit order placed by the Reporting Person during an open window period.

2. The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $590.00 to $590.72. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.

3. On November 21, 2025, the Reporting Person gifted 170 shares of common stock to a donor-advised fund.

4. The option vested in full on October 27, 2025.

Remarks:

	/s/ Stephen P. Ewald, Attorney-in-Fact for Kevin M. Brady	11/25/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Medpace (MEDP) report for its CFO?

Medpace reported that its CFO & Treasurer, Kevin M. Brady, exercised an employee stock option for 3,000 shares of common stock and sold 3,000 shares of common stock on 11/21/2025.

At what prices did the Medpace (MEDP) CFO exercise and sell shares?

Kevin M. Brady exercised an employee stock option at an exercise price of $166.73 per share and sold 3,000 shares at a weighted average price of $590.35 per share, with individual trades between $590.00 and $590.72.

How many Medpace (MEDP) shares does the CFO own after the Form 4 transactions?

Following the reported exercise, sale, and gift, Kevin M. Brady directly beneficially owned 5,830 shares of Medpace common stock.

Did the Medpace (MEDP) CFO make any charitable gifts of stock?

Yes. On November 21, 2025, Kevin M. Brady gifted 170 shares of Medpace common stock to a donor-advised fund.

What happened to the Medpace (MEDP) employee stock option reported on the Form 4?

The employee stock option for 3,000 shares of Medpace common stock vested in full on October 27, 2025 and was fully exercised on 11/21/2025, leaving 0 derivative securities from that grant beneficially owned afterward.

What role does the reporting person hold at Medpace (MEDP)?

The reporting person, Kevin M. Brady, is an officer of Medpace Holdings, Inc., serving as CFO & Treasurer.